UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
X QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended October 1, 2006
OR
TRANSITION REPORT
PURSUANT TO SECTION 13
OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition
period from________to_______
COMMISSION FILE
NUMBER 1-3619
----
PFIZER INC.
(Exact name of registrant as specified in its charter)
DELAWARE
(State of Incorporation)
13-5315170
(I.R.S. Employer Identification No.)
235
East 42nd Street, New York, New York 10017
(Address of principal executive offices) (zip
code)
(212) 573-2323
(Registrant's telephone number)
Indicate by check mark whether the registrant (1) has
filed all reports required to be filed by Section 13 or 15(d) of the
Securities Exchange Act of 1934 during the preceding 12 months (or for such
shorter period that the registrant was required to file such reports) and (2)
has been subject to such filing requirements for the past 90 days.
YES X NO
Indicate by check mark whether the registrant is a large
accelerated filer, an accelerated filer, or a non-accelerated filer. See
definition of "accelerated filer and large accelerated filer" in
Rule 12b-2 of the Exchange Act (Check one):
Large accelerated filer X
Accelerated Filer Non-accelerated
filer
Indicate by check mark whether the registrant is a shell
company (as defined in Rule 12b-2 of the Exchange Act).
YES NO X
At October 31, 2006, 7,210,444,662 shares of the
issuer's voting common stock were outstanding.
FORM 10-Q
For the Quarter
Ended
October 1, 2006
Table
of Contents
PART I. FINANCIAL
INFORMATION
Page
Item 1.
Financial Statements:
Condensed
Consolidated Statements of Income for the three months and nine months ended October
1, 2006 and October 2, 2005
Condensed
Consolidated Balance Sheets as of October 1, 2006 and
December 31, 2005
Condensed
Consolidated Statements of Cash Flows for the nine months ended October 1,
2006 and October 2, 2005
Notes to
Condensed Consolidated Financial Statements
Review Report
of Independent Registered Public Accounting Firm
25
Item 2.
Management's
Discussion and Analysis of Financial Condition and Results of Operations
26
Item 3.
Quantitative
and Qualitative Disclosures About Market Risk
57
Item 4.
Controls and
Procedures
57
PART II. OTHER
INFORMATION
Item 1.
Legal
Proceedings
58
Item 1A.
Risk Factors
59
Item 2.
Unregistered
Sales of Equity Securities and Use of Proceeds
59
Item 3.
Defaults Upon
Senior Securities
59
Item 4.
Submission of
Matters to a Vote of Security Holders
59
Item 5.
Other
Information
59
Item 6.
Exhibits
60
Signature
61
PART
I - FINANCIAL INFORMATION
Item 1. Financial Statements.
PFIZER INC AND
SUBSIDIARY COMPANIES
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(UNAUDITED)
Three Months Ended
Nine Months Ended
(millions,
except per common share data)
Oct. 1,
2006
Oct. 2,
2005
Oct. 1,
2006
Oct. 2,
2005
Revenues
12,280
11,263
35,768
34,858
Costs
and expenses:
Cost of sales(a)
1,962
1,611
5,423
5,250
Selling, informational and administrative expenses(a)
3,751
3,526
11,027
10,958
Research and development expenses(a)
1,902
1,739
5,187
5,287
Amortization of intangible assets
798
833
2,446
2,569
Merger-related in-process research and development
charges
1,390
513
1,652
Restructuring charges and merger-related costs
249
303
816
782
Other (income)/deductions - net
(343)
(151)
(958)
703
Income from continuing operations before provision
for taxes on income and minority interests
3,961
2,012
11,314
7,657
Provision for taxes on income
717
530
1,769
2,642
Minority interests
10
Income from continuing operations
3,239
1,479
9,535
5,009
Discontinued operations:
Income from discontinued operations - net
of tax
120
107
330
299
Gains on sales of discontinued
operations - net of tax
23
44
Discontinued operations - net of tax
123
110
353
343
Net income
3,362
1,589
9,888
5,352
Earnings
per common share - basic:
Income from continuing operations
0.45
0.20
1.31
0.68
Discontinued operations - net of tax
0.02
0.02
0.05
0.05
Net income
0.47
0.22
1.36
0.73
Earnings
per common share - diluted:
Income from continuing operations
0.44
0.20
1.30
0.67
Discontinued operations - net of tax
0.02
0.02
0.05
0.05
Net income
0.46
0.22
1.35
0.72
Weighted-average shares used to calculate earnings
per common share:
Basic
7,228
7,333
7,275
7,372
Diluted
7,251
7,382
7,306
7,424
Cash
dividends paid per common share
0.24
0.19
0.72
0.57
(a)
Exclusive
of amortization of intangible assets, except as disclosed in Note 12B, Goodwill
and Other Intangible Assets: Other Intangible Assets.
See accompanying
Notes to Condensed Consolidated Financial Statements.
PFIZER INC AND
SUBSIDIARY COMPANIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(UNAUDITED)
(millions
of dollars)
Oct. 1,
2006*
Dec. 31,
2005**
ASSETS
Current Assets
Cash and cash
equivalents
1,177
2,247
Short-term
investments
11,654
19,979
Accounts
receivable, less allowance for doubtful accounts
9,177
9,103
Short-term
loans
460
510
Inventories
6,167
5,478
Prepaid
expenses and taxes
3,281
2,859
Assets of
discontinued operations and other assets held for sale
6,805
6,659
Total current assets
38,721
46,835
Long-term
investments and loans
2,845
2,497
Property, plant and equipment, less
accumulated depreciation
16,417
16,233
Goodwill
21,051
20,985
Identifiable
intangible assets, less accumulated amortization
25,323
26,244
Other assets,
deferred taxes and deferred charges
4,228
4,176
Total assets
108,585
116,970
LIABILITIES
AND SHAREHOLDERS' EQUITY
Current Liabilities
Short-term
borrowings, including current portion of long-term debt
2,508
11,589
Accounts
payable
1,742
2,073
Dividends
payable
1,772
Income taxes
payable
5,209
3,618
Accrued compensation
and related items
1,533
1,602
Other current
liabilities
5,271
6,521
Liabilities of
discontinued operations and other liabilities held for sale
1,423
1,237
Total current liabilities
17,688
28,412
Long-term debt
5,561
6,347
Pension benefit
obligations
2,636
2,681
Postretirement
benefit obligations
1,368
1,424
Deferred taxes
8,838
9,707
Other
noncurrent liabilities
2,782
2,635
Total liabilities
38,873
51,206
Shareholders' Equity
Preferred stock
146
169
Common stock
441
439
Additional
paid-in capital
68,865
67,759
Employee
benefit trust, at fair value
(845)
(923)
Treasury stock
(44,256)
(39,767)
Retained
earnings
43,991
37,608
Accumulated
other comprehensive income
1,370
479
Total shareholders' equity
69,712
65,764
Total liabilities and shareholders'
equity
108,585
116,970
* Unaudited.
** Condensed from audited
financial statements.
See accompanying
Notes to Condensed Consolidated Financial Statements.
PFIZER INC AND
SUBSIDIARY COMPANIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)
Nine Months Ended
(millions
of dollars)
Oct. 1,
2006
Oct. 2,
2005
Operating Activities:
Net income
9,888
5,352
Adjustments to reconcile net income to net cash
provided by operating activities:
Depreciation and amortization
4,026
4,143
Share-based compensation expense
506
121
Merger-related in-process research and development
charges
513
1,652
Intangible asset impairments and other associated
non-cash charges
--
1,216
Gains on disposal of investments, products and
product lines
(201)
(58)
Gains on sales of discontinued operations
(37)
(72)
Deferred taxes from continuing operations
(1,333)
(1,088)
Other deferred taxes
67
(33)
Other non-cash adjustments
180
290
Changes in assets and liabilities (net of businesses
acquired and divested)
(491)
(1,527)
Net
cash provided by operating activities
13,118
9,996
Investing
Activities:
Purchases of property, plant and equipment
(1,438)
(1,493)
Purchases of short-term investments
(8,472)
(16,840)
Proceeds from redemptions of short-term investments
17,346
23,179
Purchases of long-term investments
(835)
(650)
Proceeds from redemptions of long-term investments
229
655
Purchases of other assets
(118)
(392)
Proceeds from sales of other assets
Proceeds from the sales of businesses, products and
product lines
22
108
Acquisitions, net of cash acquired
(1,989)
(2,104)
Other investing activities
(82)
238
Net
cash provided by investing activities
4,666
2,707
Financing
Activities:
Increase in short-term borrowings, net
993
Principal payments on short-term borrowings
(11,721)
(5,274)
Proceeds from issuances of long-term debt
1,051
Principal payments on long-term debt
(55)
(1,042)
Purchases of common stock
(4,496)
(3,415)
Cash dividends paid
(5,211)
(4,177)
Stock option transactions and other
593
346
Net cash used in financing activities
(18,846)
(13,548)
Effect of exchange-rate changes on cash and cash
equivalents
(8)
(4)
Net decrease in cash and cash equivalents
(1,070)
(849)
Cash and cash equivalents at beginning of period
2,247
1,808
Cash and cash equivalents at end of period
1,177
959
Supplemental Cash Flow Information:
Cash paid during the period for:
Income taxes
2,031
3,738
Interest
579
485
See accompanying
Notes to Condensed Consolidated Financial Statements.
PFIZER
INC AND SUBSIDIARY COMPANIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
Note 1. Basis of
Presentation
We prepared the condensed
consolidated financial statements following the requirements of the Securities
and Exchange Commission (SEC) for interim reporting. As permitted under those
rules, certain footnotes or other financial information that are normally
required by accounting principles generally accepted in the United States of
America (GAAP) can be condensed or omitted. Balance sheet amounts and operating
results for subsidiaries operating outside the U.S. are as of and for the
three-month and nine-month periods ended August 27, 2006 and August 28,
2005.
We made certain reclassifications to
the 2005 condensed consolidated financial statements to conform to the 2006
presentation. These reclassifications are primarily related to discontinued
operations (see Note 3, Discontinued Operations), as well as to better
reflect jurisdictional netting of deferred taxes.
Revenues, expenses, assets and
liabilities can vary during each quarter of the year. Therefore, the results
and trends in these interim financial statements may not be representative of
those for the full year.
We are responsible for the unaudited
financial statements included in this document. The financial statements
include all normal and recurring adjustments that are considered necessary for
the fair presentation of our financial position and operating results.
The information included in this
Quarterly Report on Form 10-Q should be read in conjunction with the
consolidated financial statements and accompanying notes included in Pfizer's
Annual Report on Form 10-K for the year ended December 31, 2005.
Note 2. Acquisitions
On May 16, 2006, we completed the
acquisition of all of the outstanding shares of Rinat Neuroscience Corp., a
biologics company with several new
central-nervous-system product candidates. In connection with the
acquisition, as part of our preliminary purchase price allocation, we recorded $478 million,